News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
R3 Seminar Recap: Using RECOVER biosamples to advance your research
On January 13, 2026, RECOVER hosted the second webinar in its 2-part series to help prospective researchers use biosamples from the initiative’s observational studies. RECOVER has made over 1.4 million biosamples available for study across the human lifespan, including 24,000 samples from its tissue pathology (autopsy) study. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
148 Results
148 Results
Insights from RECOVER’s pediatric study can inform future clinical trials
Findings from RECOVER’s pediatric observational study are an important first step toward including children in Long COVID clinical trials.
Feature
First webinar of Long COVID treatment initiative highlights early progress
On November 21, NIAID and FNIH launched its first in a series of online webinars highlighting recent progress in the new Researching COVID to Enhance Recovery - Treating Long COVID (RECOVER-TLC) program.
News Release
RECOVER Research Update: November 2024
Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.
Research Update
R3 Seminar Recap: Patterns of PASC with Initial COVID-19 Infections and Reinfections: EHR Insights
During the October 29th RECOVER Research Review (R3) Seminar, researchers highlighted patterns in electronic health record (EHR) data in patients who developed Long COVID after a first, or subsequent COVID-19 reinfection. By reviewing patient medical records from as early as March 2020, the findings from these studies provide insights into potential risks associated with developing Long COVID.
R3 Seminar Recap
NIH to share RECOVER-TLC updates during November 21 webinar
NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.
Announcement
NIH invites public participation to inform future Long COVID clinical trials
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Feature
R3 Seminar Recap: Advancing Long COVID Research by Fostering Collaboration between RECOVER and the All of Us Research Program
During the October 8th RECOVER Research Review (R3) Seminar, researchers described how RECOVER and the All of Us Research Program collaborate to advance our understanding of Long COVID. These different National Institutes of Health (NIH) initiatives are sharing health data and developing innovative tools to gain important insights from that data.
R3 Seminar Recap
RECOVER-ENERGIZE enrolls first clinical trial participant
A research team at RECOVER’s South Dakota study site prioritizes diversity and accessibility in clinical trial enrollment.
Feature